Functional analysis of transactivation by mutants of hepatitis B virus X gene in human hepatocellular carcinoma

Oncology Reports

Volumn 14, Issue 2, 2005, Pages 495-499

  Minemura, Masami ^a   Shimizu, Yukihiro ^a   Hirano, Katsuharu ^a   Nakayama, Yasuhiro ^a   Tokimitsu, Yoshiharu ^a   Tajiri, Kazuto ^a   Yamada, Kazuki ^a   Xue, Feng ^a   Takahara, Terumi ^a   Watanabe, Akiharu ^a   Sugiyama, Toshiro ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

HBV; Mutation; Transactivation; X gene

Indexed keywords

HEPATITIS B VIRUS X PROTEIN; TRANSACTIVATOR PROTEIN;

ANIMAL; ARTICLE; AVIAN SARCOMA VIRUS; CELL FREE SYSTEM; GENE VECTOR; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; HUMAN; LIVER CELL CARCINOMA; METABOLISM; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY; PROTEIN SYNTHESIS; RABBIT; RETICULOCYTE; SEQUENCE HOMOLOGY; TRANSACTIVATION; TUMOR CELL LINE;

ANIMALS; AVIAN SARCOMA VIRUSES; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL-FREE SYSTEM; GENETIC VECTORS; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN BIOSYNTHESIS; RABBITS; RETICULOCYTES; SEQUENCE HOMOLOGY, NUCLEIC ACID; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 24744451230     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.14.2.495     Document Type: Article

References (29)

1. Tabor E: Strongly supported features of the association between hepatitis B virus and hepatocellular carcinoma. In: Etiology, Pathology, and Treatment of Hepatocellular Carcinoma in North America. Tabor E, Di Bisceglie AM and Purcell RH (eds). The Woodlands, TX, pp 107-117, 1991.
2. Henkler F and Koshy R: Hepatitis B virus transcriptional ctivators: mechanisms and possible role in oncogenesis. J Viral Hepatol 3: 109-121, 1996. (Pubitemid 126734177)
3. Diamantis ID, McGandy CE, Chen TJ, Liaw YF, Gudat F and Bianchi L: Hepatitis B X-gene expression in hepatocellular carcinoma. J Hepatol 15: 400-403, 1992.
4. Paterlini P, Poussin K, Kew M, Franco D and Brechot C: Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma. Hepatology 21: 313-321, 1995.
5. Kim CM, Koike K, Saito I, Miyamura T and Jay G: HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351: 317-320, 1991. (Pubitemid 21896589)
6. Hsia CC, Yuwen H and Tabor E: Hot-spot mutations in hepatitis B virus X gene in hepatocellular carcinoma. Lancet 348: 625-626, 1996. (Pubitemid 26283926)
7. Hsia CC, Nakashima Y and Tabor E: Deletion mutants of the hepatitis B virus X gene in human hepatocellular carcinoma. Biochem Biophys Res Commun 241: 726-729, 1997. (Pubitemid 28036725)
8. Okamoto H, Tsuda F, Akahane Y, Sugai Y, Yoshiba M, Moriyama K, Tanaka T, Miyakawa Y and Mayumi M: Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen. J Virol 68: 8102-8110, 1994.
9. Takahashi K, Aoyama K, Ohno N, Iwata K, Akahane Y, Baba K, Yoshizawa H and Mishiro S: The precore/core promoter mutant (T1762A1764) of hepatitis B virus: clinical significance and an easy method for detection. J Gen Virol 76: 3159-3164, 1995. (Pubitemid 26003128)
10. Gunther S, Piwon N, Iwanska A, Schilling R, Meisel H and Will H: Type, prevalence, and significance of core promoter/enhancer II mutations in hepatitis B viruses from immuno-suppressed patients with severe liver disease. J Virol 70: 8318-8331, 1996. (Pubitemid 26378406)
11. Moriyama K, Okamoto H, Tsuda F and Mayumi M: Reduced precore transcription and enhanced core-pregenome transcription of hepatitis B virus DNA after replacement of the precore-core promoter with sequences associated with e antigen-seronegative persistent infections. Virology 226: 269-280, 1996. (Pubitemid 27025807)
12. Moriyama K: Reduced antigen production by hepatitis B virus harbouring nucleotide deletions in the overlapping X gene and precore-core promoter. J Gen Virol 78: 1479-1486, 1997.
13. Scaglioni PP, Melegari M and Wands JR: Biologic properties of hepatitis B viral genomes with mutations in the precore promoter and precore open reading frame. Virology 233: 374-381, 1997. (Pubitemid 27314823)
14. Kozak M: At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells. J Mol Biol 196: 947-950, 1987.
15. Baumert TB, Rogers SA, Hasegawa K and Liang TJ: Two core promoter mutations identified in a hepatitis B virus associated with fulminant hepatitis result in enhanced viral replication. J Clin Invest 98: 2268-2278, 1996.
16. Roelant C, Scheirer W and Burns DA: Accelerating the pace of luciferase reporter gene assays. Biotechniques 20: 914-917, 1996. (Pubitemid 26171892)
17. Arii M, Takada S and Koike K: Identification of three essential regions of hepatitis B virus X protein for trans-activation function. Oncogene 7: 397-403, 1992.
18. Kao JH, Chen PJ, Lai MY and Chen DS: Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers. Gastroenterology 124: 327-334, 2003.
19. Repp R, Keller C, Borkhardt A, Csecke A, Schaefer S, Gerlich WH and Lampert F: Detection of a hepatitis B virus variant with a truncated X gene and enhancer II. Arch Virol 125: 299-304, 1992.
20. Uchida T, Shimojima S, Gotoh K, Shikata T and Mima S: Pathology of livers infected with 'silent' hepatitis B virus mutant. Liver 14: 251-256, 1994. (Pubitemid 24319994)
21. Feitelson MA, Duan LX, Guo J, Sun B, Woo J, Steensma K, Horiike N and Blumberg BS: X region deletion variants of hepatitis B virus in surface antigen-negative infections and non-A, non-B hepatitis. J Infect Dis 172: 713-722, 1995.
22. Fukuda R, Ishimura N, Kushiyama Y, Moriyama N, Ishihar S, Chowdhury A, Tokuda A, Sakai S, Akagi S, Watanabe M and Fukumoto S: Hepatitis B virus with X gene mutation is associated with the majority of serologically 'silent' non-B, non-C chronic hepatitis. Microbiol Immunol 40: 481-488, 1996. (Pubitemid 126481263)
23. Kumar V, Jayasuryan N and Kumar R: A truncated mutant (residues 58-140) of the hepatitis B virus X protein retains transactivation function. Proc Natl Acad Sci USA 93: 5647-5652, 1996. (Pubitemid 26159506)
24. Feitelson MA, Zhu M, Duan LX and London WT: Hepatitis B x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma. Oncogene 8: 1109-1117, 1993. (Pubitemid 23129832)
25. Wang XW, Gibson MK, Vermeulen W, Yeh H, Forrester K, Sturzbecher HW, Hoeijmakers JH and Harris CC: Abrogation of p53 induced apoptosis by the hepatitis B virus X gene. Cancer Res 55: 6012-6016, 1995.
26. Truant R, Antunovic J, Greenblatt J, Prives C and Cromlish JA: Direct interaction of the hepatitis B virus HBx protein with p53 leads to inhibition by HBx of p53 response element-directed transactivation. J Virol 69: 1851-1859, 1995.
27. Ueda H, Ullrich SJ, Gangemi JD, Kappel CA, Ngo L, Feitelson MA and Jay G: Functional inactivation but not structural mutation of p53 causes liver cancer. Nat Genet 9: 41-47, 1995.
28. Lin Y, Nomura T, Yamashita T, Dorjsuren D, Tang H and Murakami S: The transactivation and p53-interacting functions of hepatitis B virus X protein are mutually interfering but distinct. Cancer Res 57: 5137-5142, 1997. (Pubitemid 27498132)
29. Shirakata Y and Koike K: Hepatitis B virus X protein induces cell death by causing loss of mitochondrial membrane potential. J Biol Chem 278: 22071-22078, 2004.